Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 50 min ago
Peer-reviewedCC BY 4.0Frontiers in Oncology

Diagnosis of leptomeningeal metastasis with concurrent tuberculous meningitis assisted by cerebrospinal fluid metagenomic next-generation sequencing combined with copy number variation analysis: a case report

Abstract

Concurrent tuberculous meningitis (TBM) and leptomeningeal metastasis from lung adenocarcinoma (LUAD-LM) are exceptionally rare and pose significant diagnostic challenges. Overlapping clinical and neuroimaging features often lead to misdiagnosis or diagnostic delay. Here, we report a 69-year-old woman with a prior history of bilateral invasive lung adenocarcinoma lesions who had undergone surgical resection. Although genetic testing identified an epidermal growth factor receptor (EGFR) mutation, targeted therapy was not initiated at that time. Two weeks before admission, the patient developed progressive dizziness and headache, which rapidly evolved into cognitive impairment and intractable projectile vomiting. Contrast-enhanced magnetic resonance imaging (MRI) revealed hydrocephalus and diffuse leptomeningeal enhancement. Cerebrospinal fluid (CSF) cytology demonstrated atypical cells, initially suggesting LUAD-LM. However, metagenomic next-generation sequencing combined with copy number variation analysis (mNGS-CNV) of the CSF detected both multiple chromosomal copy number alterations and Mycobacterium tuberculosis. These findings supported the concurrent diagnoses of LUAD-LM and TBM. The patient was treated with EGFR-targeted therapy in combination with a four-drug anti-tuberculosis regimen. At one-year follow-up, her condition remained stable. This case highlights the potential value of CSF mNGS-CNV in recognizing concurrent infectious and neoplastic meningeal diseases from a single CSF specimen.

Related

  1. Development and Temporal Validation of a Three-Metabolite Cerebrospinal Fluid Model for the Diagnosis of Leptomeningeal Metastasis from Solid Tumors
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Ommaya Reservoir-Based Cerebrospinal Fluid Chemotherapy for Leptomeningeal Metastasis in the Era of Targeted Therapy: Safety, Survival, and Exploratory Prognostic Factors from a Single-Center Cohort
    Huaixu Li, Hongqing Cai, Xiaohong Lu +4
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
  3. EGFR-mutant lung adenocarcinoma with leptomeningeal metastasis after osimertinib treatment: intrathecal chemotherapy combined with targeted therapy supported by cerebrospinal fluid next generation sequencing — a case report
    Xinli Gan, Xin Jin, Mingmei Pan +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  4. Tuberculous meningitis diagnosed on repeat cerebrospinal fluid analysis after unremarkable initial findings: a case report.
    Yoonjeong Na, Jung-Ju Lee, Byung-Kun Kim +2
    Encephalitis (Seoul, Korea)Peer-reviewedCC BY-NCFull textSurgery & anaesthesiaEurope PMC
  5. Leptomeningeal metastasis of lung adenocarcinoma presenting as cauda equina syndrome: a case report and literature review
    Xiaofeng Chen, Haijuan Lv
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
BibTeX
@article{zhang2026diagnosis,
  title = {{Diagnosis of leptomeningeal metastasis with concurrent tuberculous meningitis assisted by cerebrospinal fluid metagenomic next-generation sequencing combined with copy number variation analysis: a case report}},
  author = {Ting Zhang and Xiaofeng Xiong and Miaoping Zhang and Qian Liu and Xuejun Fu and Yuanhong Chen and Ying Huang and Qianhui Xu},
  journal = {Frontiers in Oncology},
  year = {2026},
  month = nov,
  doi = {10.3389/fonc.2026.1819438},
  url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1819438},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Diagnosis of leptomeningeal metastasis with concurrent tuberculous meningitis assisted by cerebrospinal fluid metagenomic next-generation sequencing combined with copy number variation analysis: a case report
AU  - Ting Zhang
AU  - Xiaofeng Xiong
AU  - Miaoping Zhang
AU  - Qian Liu
AU  - Xuejun Fu
AU  - Yuanhong Chen
AU  - Ying Huang
AU  - Qianhui Xu
PY  - 2026
DA  - 2026/11/11
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1819438
UR  - https://www.frontiersin.org/articles/10.3389/fonc.2026.1819438
AB  - Concurrent tuberculous meningitis (TBM) and leptomeningeal metastasis from lung adenocarcinoma (LUAD-LM) are exceptionally rare and pose significant diagnostic challenges. Overlapping clinical and neuroimaging features often lead to misdiagnosis or diagnostic delay. Here, we report a 69-year-old woman with a prior history of bilateral invasive lung adenocarcinoma lesions who had undergone surgical resection. Although genetic testing identified an epidermal growth factor receptor (EGFR) mutation, targeted therapy was not initiated at that time. Two weeks before admission, the patient developed progressive dizziness and headache, which rapidly evolved into cognitive impairment and intractable projectile vomiting. Contrast-enhanced magnetic resonance imaging (MRI) revealed hydrocephalus and diffuse leptomeningeal enhancement. Cerebrospinal fluid (CSF) cytology demonstrated atypical cells, initially suggesting LUAD-LM. However, metagenomic next-generation sequencing combined with copy number variation analysis (mNGS-CNV) of the CSF detected both multiple chromosomal copy number alterations and Mycobacterium tuberculosis. These findings supported the concurrent diagnoses of LUAD-LM and TBM. The patient was treated with EGFR-targeted therapy in combination with a four-drug anti-tuberculosis regimen. At one-year follow-up, her condition remained stable. This case highlights the potential value of CSF mNGS-CNV in recognizing concurrent infectious and neoplastic meningeal diseases from a single CSF specimen.
SN  - 2234-943X
ER  -